Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tozadenant Phase 2b Study in Parkinson's Disease
NCT01283594Phase 3Completed
- Sponsor
- Biotie Therapies
- Start
- Mar 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of tozadenant in Parkinson's disease (PD), sponsored by Biotie Therapies. Started Mar 2011; status: completed.
02
Drugs
tozadenant
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01283594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01283594.